Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors

Experimental Hematology

Volumn 32, Issue 6, 2004, Pages 536-546

  Schroers, Roland ^a   Hildebrandt, York ^a   Hasenkamp, Justin ^a   Glass, Bertram ^a   Lieber, André ^b   Wulf, Gerald ^a   Piesche, Matthias ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CHIMERIC PROTEIN; MITOGENIC AGENT;

ARTICLE; CELL LINE; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; KIDNEY CELL; LEUKEMIA CELL; LEUKOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; T LYMPHOCYTE; TRANSGENE;

ADENOVIRUSES, HUMAN; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD46; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHIMERA; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HL-60 CELLS; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES;

CUCUMBER MOSAIC VIRUS;

EID: 2942590495     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2004.03.010     Document Type: Article

References (50)

1. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature. 411:2001;380-384
2. Biron C.A., Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol. 13:2001;458-464
3. Long E.O. Tumor cell recognition by natural killer cells. Semin Cancer Biol. 12:2002;57-61
4. Moretta L., Bottino C., Pende D., Mingari M.C., Biassoni R., Moretta A. Human natural killer cells: their origin, receptors and function. Eur J Immunol. 32:2002;1205-1211
5. Djeu J.Y., Jiang K., Wei S. A view to a kill: Signals triggering cytotoxicity. Clin Cancer Res. 8:2002;636-640
6. Smyth M.J., Hayakawa Y., Takeda K., Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2:2002;850-861
7. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 295:2002;2097-2100
8. Smyth M.J., Godfrey D.I., Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol. 2:2001;293-299
9. Paul S., Regulier E., Poitevin Y., Hormann H., Acres R.B. The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer. Cancer Immunol Immunother. 51:2002;645-654
10. Stanislawski T., Voss R.H., Lotz C., et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat Immunol. 2:2001;962-970
11. Uherek C., Tonn T., Uherek B., et al. Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction. Blood. 100:2002;1265-1273
12. Fregeau C.J., Bleackley R.C. Factors influencing transient expression in cytotoxic T cells following DEAE dextran-mediated gene transfer. Somat Cell Mol Genet. 17:1991;239-257
13. Ebert O., Finke S., Salahi A., et al. Lymphocyte apoptosis: Induction by gene transfer techniques. Gene Ther. 4:1997;296-302
14. + cells via electroporation-mediated gene delivery. Gene Ther. 7:2000;1431-1437
15. Engels B., Cam H., Schuler T., et al. Retroviral vectors for high-level transgene expression in T lymphocytes. Hum Gene Ther. 14:2003;1155-1168
16. Schroers R., Davis C.M., Wagner H.J., Chen S.Y. Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection. Gene Ther. 9:2002;889-897
17. Chinnasamy D., Chinnasamy N., Enriquez M.J., Otsu M., Morgan R.A., Candotti F. Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins. Blood. 96:2000;1309-1316
18. Hacein-Bey-Abina S., von Kalle C., Schmidt M., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 348:2003;255-256
19. Fischer A. Cautious advance. Gene therapy is more complex than anticipated. EMBO Rep. 1:2000;294-296
20. Li Z., Dullmann J., Schiedlmeier B., et al. Murine leukemia induced by retroviral gene marking. Science. 296:2002;497
21. Baum C., Dullmann J., Li Z.X., et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood. 101:2003;2099-2114
22. Lu M., Zhang N., Maruyama M., Hawley R.G., Ho A.D. Retrovirus-mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation. Hum Gene Ther. 7:1996;2263-2271
23. Kay M.A., Glorioso J.C., Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med. 7:2001;33-40
24. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrin-α-V- β-3 and integrin-α-V-β-5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319
25. Yotnda P., Onishi H., Heslop H.E., et al. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther. 8:2001;930-937
26. + cells by a retargeted adenovirus vector. J Virol. 74:2000;2567-2583
27. Gaggar A., Shayakhmetov D.M., Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med. 9:2003;1408-1412
28. + peripheral blood derived dendritic cells with a model tumour antigen is more efficient with chimeric Ad5/11 and Ad5/35 adenoviruses than Ad5. Mol Ther. 5:2002;S110
29. Rea D., Havenga M.J., van Den Assem M., et al. Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol. 166:2001;5236-5244
30. Gong J.H., Maki G., Klingemann H.G. Characterization of a human cell line (Nk-92) with phenotypical and functional characteristics of activated natural-killer-cells. Leukemia. 8:1994;652-658
31. Davis A.R., Meyers K., Wilson J.M. High throughput method for creating and screening recombinant adenoviruses. Gene Ther. 5:1998;1152
32. Schroers R., Sinha I., Segall H., et al. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther. 1:2000;171-179
33. Schroers R., Chen S.Y. Lentiviral transduction of human dendritic cells. Methods Mol Biol. 246:2004;451-459
34. Segerman A., Atkinson J.P., Marttila M., Dennerquist V., Wadell G., Arnberg N. Adenovirus type 11 uses CD46 as a cellular receptor. J Virol. 77:2003;9183-9191
35. Costello E., Munoz M., Buetti E., Meylan P.R., Diggelmann H., Thali M. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Ther. 7:2000;596-604
36. Huang S., Endo R., Nemerow G.R. Upregulation of integrins α v β 3and α v β 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol. 69:1995;2257-2263
37. Nishimura N., Nishioka Y., Shinohara T., Sone S. Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells. Hum Gene Ther. 12:2001;333-346
38. Nyberg-Hoffman C., Shabram P., Li W., Giroux D., Aguilar-Cordova E. Sensitivity and reproducibility in adenoviral infectious titer determination. Nat Med. 3:1997;808-811
39. Rosenberg S.A. Progress in the development of immunotherapy for the treatment of patients with cancer. J Intern Med. 250:2001;462-475
40. Paul S., Calmel B., Acres R.B. Improvement of adoptive cellular immunotherapy of human cancer using ex vivo gene transfer. Curr Gene Ther. 2:2002;91-100
41. Liu K., Rosenberg S.A. Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity. J Immunol. 167:2001;6356-6365
42. Nagashima S., Mailliard R., Kashii Y., et al. Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo. Blood. 91:1998;3850-3861
43. Heemskerk M.H.M., Hoogeboom M., van de Meent M., de Paus R.A., Willemze R., Falkenburg J.H.F. Engineering of high-affinity minor histocompatibility antigen (mHag)-specific T lymphocytes by recombining T cell receptor chains from different mHag HA-2-specific T cell clones. Blood. 100:2002;673A
44. Korbelik M., Sun J.H., Posakony J.J. Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors. Photochem Photobiol. 73:2001;403-409
45. Liu K., Rosenberg S.A. Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent. J Immunother. 26:2003;190-201
46. Chiorean E.G., Dylla S.J., Olsen K., Lenvik T., Soignier Y., Miller J.S. BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs). Blood. 101:2003;3527-3533
47. Mentel R., Meinsen D., Pilgrim H., Herrmann B., Lindequist U. Adenovirus-receptor interaction with human lymphocytes. J Med Virol. 51:1997;252-257
48. Segerman A., Mei Y.F., Wadell G. Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines. J Virol. 74:2000;1457-1467
49. Krasnykh V.N., Mikheeva G.V., Douglas J.T., Curiel D.T. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol. 70:1996;6839-6846
50. Loser P., Jennings G.S., Strauss M., Sandig V. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFκB. J Virol. 72:1998;180-190